Results 181 to 190 of about 457,033 (338)

Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies [PDF]

, 2009
Denis Malvy, Khaled Ezzedine, Maria Mamani‐Matsuda, Brigitte Autran, Hugues Tolou, Marie‐Catherine Receveur, Thierry Pistone, Jérôme Rambert, Daniel Moynet, Djavad Mossalayi   +9 more
openalex   +1 more source

Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease

, 2023
Tanyaporn Pattarabanjird
openalex   +2 more sources

IgM paraproteins. [PDF]

Journal of Clinical Pathology, 1975
J R, Hobbs, P M, Carter, K B, Cooke, M, Foster, C J, Oon   +4 more
openaire   +2 more sources

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source

Glacier catalogue for IGM physics-informed deep-learning emulator pretraining

, 2023
Guillaume Jouvet
openalex   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab

Arthritis &Rheumatology, EarlyView.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo, Shu Su, Jingyue Liu, Junyu Lin, Jin Song, Zongwen Chen, Yuanyuan Peng, Lijun Jiang, Meng Jia, Li Wang, Xinhui Jiang, Wei Zhang, Zanhua Rong, Bo Zhao, Yajun Wang, Xuemei Tang   +15 more
wiley   +1 more source

Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies

, 2009
Eduardo Nobile‐Orazio, Claudia Giannotta, Chiara Briani   +2 more
openalex   +2 more sources

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

Arthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source

Association of rubella and parvovirus B19 IgM positivity and suspected rheumatoid arthritis: a retrospective analysis from a large US national reference laboratory (2014-2023). [PDF]

BMJ Open
Lee MK, Alfego D, Naides SJ.
europepmc   +1 more source

Two Spontaneous BALB/c Lymphomas Synthesize IgM: Monomers and Half Molecules Are Isolated and Characterized Whereas Another Molecule Resembles IgD [PDF]

, 1979
Paul E. McKeever, K. Jin Kim, Gregory B. Nero, Reuven Laskov, Ruth M. Merwin, Weltha J. Logan, Richard Asofsky   +6 more
openalex   +1 more source